Increased prostanoid dependency of arterial relaxation in Chlamydia pneamoniae-infected mice

Journal of Medical Microbiology

Volumn 55, Issue 8, 2006, Pages 1017-1021

  Törmäkangas, Liisa ^a   Ketonen, Juha ^b   Leinonen, Maija ^a   Saikku, Pekka ^c   Paakkari, Ilari ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; BACTERIAL DNA; COMPLEMENTARY DNA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; MESSENGER RNA; METHACHOLINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIUM CULTURE; BLOOD VESSEL REACTIVITY; CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HYPERCHOLESTEROLEMIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA, THORACIC; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; METHACHOLINE CHLORIDE; MICE; MICE, INBRED C57BL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NOREPINEPHRINE; PROSTAGLANDINS; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 33747063358     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46516-0     Document Type: Article

References (19)

1. Blessing, E., Lin, T.-M., Campbell, L. A., Rosenfeld, M. E., Lloyd, D. & Kuo, C. (2000). Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice. Infect Immun 68, 4765-4768.
2. Collins, S., Martin, T. L., Surwit, R. S. & Robidoux, J. (2004). Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 81, 243-248.
3. Erkkilä, L., Laitinen, K., Laurila, A., Saikku, P. & Leinonen, M. (2002). Experimental Chlamydia pneumoniae infection in NIH/S mice: effect of reinoculation with chlamydial or cell preparation on culture, PCR and histological findings of lung tissue. Vaccine 20, 2318-2324.
4. Erkkilä, L., Laitinen, K., Haasio, K., Tiirola, T., Jauhiainen, M., Lehr, H. A., Aalto-Setälä, K., Saikku, P. & Leinonen, M. (2004). Heat shock protein 60 autoimmunity and early lipid lesions in cholesterol-fed C57BL/6JBom mice during Chlamydia pneumoniae infection. Atherosclerosis 177, 321-328.
5. Feletou, M. & Vanhoutte, P. M. (1999). The third pathway, endothelium-dependent hyperpolarization. J Physiol Pharmacol 50, 525-534.
6. Hu, H., Pierce, G. N. & Zhong, G. (1999). The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 103, 747-753.
7. Laskowitz, D. T., Lee, D. M., Schmechel, D. & Staats, H. F. (2000). Altered immune responses in apolipoprotein E-deficient mice. J Lipid Res 41, 613-620.
8. Leinonen, M. & Saikku, P. (2002). Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2, 11-17.
9. Liuba, P., Karnani, P., Pesonen, E., Paakkari, I., Forslid, A., Johansson, L., Persson, K., Wadström, T. & Laurini, R. (2000). Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice. Circulation 102, 1039-1044.
10. Liuba, P., Pesonen, E., Paakkari, I. & 8 other authors (2003). Co-infection with Chlamydia pneumoniae and Helicobacter pylori results in vascular endothelial dysfunction and enhanced VCAM-1 expression in apoE-knockout mice. J Vasc Res 40, 115-122.
11. Moazed, T. C., Kuo, C., Grayston, J. T. & Campbell, L. A. (1997). Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 175, 883-890.
12. Moazed, T. C., Campbell, L. A., Rosenfeld, M. E., Grayston, J. T. & Kuo, C. C. (1999). Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis 180, 238-241.
13. Paigen, B., Morrow, A., Brandon, C., Mitchell, D. & Holmes, P. (1985). Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57, 65-73.
14. Ross, R. (1999). Atherosclerosis - an inflammatory disease. N Engl J Med 340, 115-126.
15. 2 and MMP-1 expression. Biochem Biophys Res Commun 320, 738-744.
16. Simpson, D. A. C., Feeney, S., Boyle, C. & Stitt, A. W. (2000). Retinal VEGF mRNA measured by SYBR green I fluorescence: a versatile approach to quantitative PCR. Mol Vis 6, 178-183.
17. 2. Am J Physiol Gastrointest Liver Physiol 286, G148-G156.
18. Törmäkangas, L., Erkkilä, L., Korhonen, T., Tiirola, T., Bloigu, A., Saikku, P. & Leinonen, M. (2005a). Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice. Infect Immun 73, 6458-6466.
19. Törmäkangas, L., Vuorela, P., Saario, E., Leinonen, M., Saikku, P. & Vuorela, H. (2005b). In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model. Biochem Pharmacol 70, 1222-1230.